Ryan C. Lynch, MD
Before I started medical school, I had the opportunity to work in a research lab that studied the development of blood vessels in tumors. Many of the lab’s ongoing projects were being translated into novel therapeutics. Becoming an oncologist was a way I could help bring those therapies to patients. As my training progressed, I worked in oncology clinics and witnessed the translation from bench to bedside firsthand. That experience inspired me to work directly with patients while also exploring novel treatments for lymphomas and chronic lymphocytic leukemia through clinical trials.
Every person handles their cancer diagnosis differently; it can set off a wide range of feelings and life changes that are unique to each individual. I enjoy connecting with patients and families, learning about your goals for care, your hopes, your plans for the future and your concerns. It is my job to help you understand and feel comfortable with your treatment plan, whether you’re receiving a standard therapy, choosing a novel approach or participating in a clinical trial.
Specialty: Medical Oncology
I am a board-certified hematologist-oncologist who specializes in caring for patients with lymphomas and chronic lymphocytic leukemia (CLL). I am also involved in clinical research for these diseases. While many excellent therapies are available for CLL and lymphomas, they don’t work for every patient. I conduct clinical trials to optimize treatments and bring novel therapeutic agents to the clinic.
Combining chemotherapy with targeted medicines can cure diffuse large B-cell lymphoma (DLBCL), but cure rates have been stagnant for more than 10 years. That’s why Seattle Cancer Care Alliance (SCCA) is leading research and clinical trials that aim to bring cures to a larger percentage of patients with DLBCL.
We make promising new treatments available to you through studies called clinical trials led by SCCA doctors. Many of these trials at SCCA have led to FDA-approved treatments and have improved standards of care globally. Together, you and your doctor can decide if a study is right for you.
Many of our SCCA physicians conduct ongoing research to improve standards of patient care. Their work is evaluated by other physicians and selected for publication to the United States National Library of Medicine, the largest medical library in the world. See scientific papers this SCCA provider has written.
SCCA providers are often asked to give their medical expertise for press and news publications. Read articles by or about this SCCA provider.
SCCA’s Dr. Ryan Lynch was quoted in a Reuters Health story about results of the first prospective clinical trial of combination immunotherapy in angiosarcoma.
Your care team
SCCA accepts most national private health insurance plans as well as Medicare. We also accept Medicaid for people from Washington, Alaska, Montana and Idaho. We are working to ensure that everyone, no matter what their financial situation, has access to the care they need.